All questions are shown as received by the Trust.
In the past 3 months, how many patients have been treated for Colorectal Cancer [CRC] with the following regimens?
Can you please provide the total number of patients treated for CRC with each product and the total number of Metastatic patients treated with each product for CRC in the table below.
Aflibercept plus chemotherapy
Bevacizumab plus fluoropyrimidine-based chemotherapy
Capecitabine
CAPIRI
CAPOX
Cetuximab with FOLFIRI
Cetuximab with FOLFOX
Cetuximab as a single agent
Cetuximab with Encorafenib
Irinotecan as a single agent
FOLFIRI
FOLFOX
Fluorouracil (5FU) as a single agent
Oxaliplatin as a single agent
Nivolumab with Ipilimumab
Panitumumab with FOLFIRI
Panitumumab with FOLFOX
Panitumumab as a single agent
Pembrolizumab
Any other systemic anti-cancer therapy
Palliative care only
